What is the recommended dose of aspirin (acetylsalicylic acid) for stroke prevention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Aspirin Dose for Stroke Prevention

For stroke prevention, aspirin 75-100 mg daily is the recommended dose, balancing efficacy with safety across both primary and secondary prevention settings. 1, 2

Secondary Prevention (After Stroke or TIA)

Patients with prior ischemic stroke or TIA should receive aspirin 75-100 mg daily for long-term secondary prevention. 1, 3 This dose range provides equivalent stroke risk reduction compared to higher doses (up to 1500 mg daily) while minimizing bleeding complications. 1

Acute Phase Dosing

  • Administer aspirin 160-325 mg as a single loading dose immediately after ruling out intracranial hemorrhage on neuroimaging. 3
  • Transition to maintenance dose of 75-100 mg daily (typically 81 mg in the US) after the acute phase. 2, 3

Special Circumstances in Secondary Prevention

  • For minor ischemic stroke or high-risk TIA, consider dual antiplatelet therapy with aspirin 81 mg daily plus clopidogrel 75 mg daily for 21 days, then transition to single antiplatelet therapy. 3
  • For patients with mechanical prosthetic heart valves who experience stroke despite adequate anticoagulation, add aspirin 75-100 mg daily to warfarin (INR 2.5-3.5) if bleeding risk is acceptable. 1

Primary Prevention

For primary stroke prevention in high-risk individuals, aspirin 75-100 mg daily is recommended when cardiovascular risk is sufficiently elevated to outweigh bleeding risks. 1, 2, 4

Specific High-Risk Populations Warranting Primary Prevention

  • Women ≥65 years with controlled blood pressure (<150/90 mmHg) and 10-year cardiovascular risk >6-10%. 2, 3
  • Patients with high-risk antiphospholipid profile (triple-positive or double-positive antiphospholipid testing, or isolated lupus anticoagulant). 1
  • Patients with systemic lupus erythematosus and high-risk antiphospholipid profile. 1
  • Diabetic patients ≥50 years with hypertension plus at least one additional major cardiovascular risk factor. 2

Why This Dose Range is Optimal

The 75-100 mg daily dose represents the sweet spot where:

  • Efficacy is maintained: Meta-analyses demonstrate that aspirin doses from 50 mg to 1500 mg provide similar relative risk reduction (approximately 15%) for stroke prevention. 1, 5
  • Toxicity is minimized: Gastrointestinal bleeding risk is dose-dependent, with higher doses (≥325 mg) conferring 2.5 times the bleeding risk compared to non-users, while lower doses (75-100 mg) reduce this risk substantially. 1, 2
  • Hemorrhagic stroke risk is acceptable: While aspirin increases hemorrhagic stroke risk by 0-2 per 1,000 persons over 5 years, this is outweighed by ischemic stroke prevention benefits at the 75-100 mg dose. 2

Common Pitfalls to Avoid

  • Do not use doses <75 mg daily: Evidence for doses below 75 mg is limited and may be insufficient for stroke prevention. 1
  • Avoid routine use of high doses (≥325 mg) for chronic prevention: Higher doses increase bleeding risk without additional efficacy for long-term stroke prevention. 1, 2
  • Do not initiate aspirin in low-risk individuals: For patients with 10-year cardiovascular risk <6%, bleeding risks outweigh minimal benefits. 2, 4
  • Always rule out intracranial hemorrhage before administering aspirin in acute stroke settings. 3

Bleeding Risk Assessment

Before initiating aspirin, assess for contraindications and high bleeding risk:

  • Absolute contraindications: Active gastrointestinal bleeding, documented aspirin allergy, bleeding disorders, clinically active hepatic disease. 2
  • High bleeding risk factors: Age >70 years, uncontrolled hypertension, concomitant NSAIDs or anticoagulants, history of gastrointestinal bleeding. 2, 4
  • Expected bleeding rates: Major gastrointestinal bleeding occurs at approximately 2-4 per 1,000 middle-aged persons (4-12 per 1,000 older persons) over 5 years with aspirin therapy. 2

Alternative for Aspirin-Intolerant Patients

For patients with documented aspirin allergy requiring antiplatelet therapy, substitute clopidogrel 75 mg daily. 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Aspirin Therapy in Clinical Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Aspirin Therapy for Stroke Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Aspirin Prophylaxis Indications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.